Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears
Science | The GuardianJul 1
In brief
This story was published by Science | The Guardian and is part of the Science coverage that Global24 monitors in real time from public sources.
The topic also appears in other newsrooms' coverage: NYT > World News, Technology | The Guardian, Sport | The Guardian published related stories in the last few hours. You can compare them below.
Contextual summary produced by Global24 from the source's public metadata.
“Some adults aged 65 and above will be able to get the drug for $50 through Medicare GLP-1, a temporary program Kathryn, a retiree who worked in healthcare, has throughout her life experienced “cyclical weight-loss, weight-gain”. “Every time”
— Excerpt from Science | The Guardian
The original content belongs to Science | The Guardian. Global24 is an aggregator and always links to the source.
